KRYS Krystal Biotech PE ratio, current and historical analysis
As of Nov 21, 2024, the KRYS stock has a PE ratio of 99.07. The calculation is based on the latest EPS of $1.84 and the stock price of $182.29 per share. A decrease of 28% has been observed in the PE ratio compared to its average of 136.9 of the last four quarters.
KRYS PE ratio history
The mean historical PE ratio of Krystal Biotech over the last eight years is 109.58. The current 99.07 P/E ratio is 10% lower than the historical average. Looking back at the last eight years, KRYS's PE ratio peaked in the Dec 2023 quarter at 310.15, with a price of $124.06 and an EPS of $0.4. The Sep 2017 quarter marked the lowest point at 0.27, with a price of $9.97 and an EPS of $37.27.
Krystal Biotech PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 310.15 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
KRYS average PE ratio chart
KRYS PE vs peers
In comparison to its peer stock ORMP, KRYS's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 21 | $93.12M |
| KRYS Krystal Biotech Inc | 99.07 | $5.24B |
| OLMA Olema Pharmaceuticals Inc | N/A | $450.93M |
| OMER Omeros Corp | N/A | $447.95M |
| OMGA Omega Therapeutics Inc | N/A | $42.96M |
| ONCT Oncternal Therapeutics Inc | N/A | $3.43M |
| ONVO Organovo Holdings Inc | N/A | $5.38M |
| ORIC Oric Pharmaceuticals Inc | N/A | $643.57M |
Frequently asked questions
What is Krystal Biotech's PE ratio?
KRYS stock has a price to earnings ratio of 99.07 as of Nov 21, 2024.
What is the highest PE ratio for KRYS?
Over the last eight years, the Dec 2023 quarter recorded the highest quarterly PE ratio at 310.15.
How does the current PE ratio for KRYS compare to its historical average?
KRYS's current price to earnings ratio is 10% below its 8-year historical average.
Why is Krystal Biotech's PE ratio so high?
KRYS's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is KRYS's PE ratio calculated (Krystal Biotech PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 21, 2024), Krystal Biotech's share price is $182.29. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.84. Therefore, Krystal Biotech's PE ratio for today is 99.07. PE RATIO(99.07) = STOCK PRICE($182.29) / TTM EPS($1.84)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.